Literatur
CH50
Technical Bulletin CH50
Immunol 2005, Daňková E. et al.: C1 INH Deficiencies and C2 Complement Deficiencies detected by Autokit CH50 using a biochemical analyzer
Immunol 2004, Daňková E. et al.: Autokit CH50 used as a screening test for complement deficiencies
Yamamoto S et al.: Automated homogeneous liposome-based assay system for total complement activity. Clin Chem 1995 Apr;41(4):586-90
HA
Papastamataki M et al. Evaluation of liver fibrosis in patients with thalassemia: the important role of hyaluronic acid. Blood Cells Mol Dis. 2010 Oct 15;45(3):215-8.
Guéchot J et al.: Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort. Clin Chim Acta 2010 Jan;
411(1-2):86-91
Euromedlab 2009, Innsbruck, Austria, Stojakovic T. et al.: Turbidimetric assay for measurement of hyaluronic acid in patients with liver cirrhosis
Guéchot J et al.: Automated assay of hyaluronic acid in serum. Immuno-analyse et biologie spécialisée (2008) 23: 148-152
AACC 2008, Washington, USA, Guéchot J. et al.: Evaluation of the first automatized hyaluronic acid assay
AACC 2007, San Diego, USA, Fujio K. et al.: Development of a hyaluronic acid detection reagent using latex agglutination method
HCC Biomarkers
HCC monothematic conference 2010, Dubrovnik, Schuhr I. et al.: Combined analysis of AFP, AFP-L3 and DCP is superior to AFP alone in the detection of HCC in European patients
APASL 2009, Istanbul, Doekmeci A.K. et al.: Diagnostic value of Lectin-reactive alpha-fetoprotein (AFP-L3) and Des-gamma-Carboxy Prothrombin (DCP) for Hepatocellular Carcinoma (HCC): First study with a Turkish patient cohort
Seminar 2009, Cairo, Waked I. et al.: Evaluation of Automated Measurement of AFP, AFP-L3 and DCP in Egyptian Patients with Hepatocellular Carcinoma in the National Liver Institute
GASL 2009, Heidelberg, Ertle J. et al.: Improved Diagnosis of HCC by Determination of the Tumor Markers Alphafetoprotein-L3 and Des-Gamma-Carboxyprothrombin (DCP): Pilot Study with a German Patient Cohort
GASL 2009, Heidelberg, Schulze-Bergkamen H. et al.: AFP, AFP-L3% and DCP levels in patients with advanced hepatocellular carcinoma treated with sorafenib
AFP-L3%/DCP combined use
Combination annotated bibliography
µTASWakoTM i30
Chang WWP et al. Microfluidic immunoassays on polymeric microchips. IVDTechnology Magazine, spring 2010: 6-11
Kagebayashi C et al. Automated immunoassay system for AFP-L3% using on-chip electrokinetic reaction and separation by affinity electrophoresis. Anal Biochem 2009, 15;388 (2): 306-11
HDL
Warnick GR et al. Evaluation of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem 2001 Sep;47(9):1579-1596
Nauk M et al. New immunoseparation-based homogeneous assay for HDL-cholesterol compared with three homogenous and two heterogeneous methods for HDL-cholesterol. Clin Chem 1998 44:7:1443-1451
LDL
Smets EM et al. Analytical performance of a direct assay for LDL-cholesterol. Clin Chem Lab Med 2001 Mar;39(3):270-280
Esteban-Salán M et al. Analytical and clinical evaluation of two homogenous assays for LDL-cholesterol in hyperlipidemic patients. Clin. Chem 2000 Aug;46(8 Pt 1):1121-1131
NEFA
Krebs M et al. Prevention of in Vitro Lipolysis by Tetrahydrolipastatin. Clin Chem 2000 46(7):950-954
Hoffmann GE et al. An Enzymatic Method for Calibration of Serum Lipase Assays. Clin Chem 1986 32/3:545-547
